4Indexed trials
drug · Product Intelligence
Rivastigmine
Pipeline Intelligence
Rivastigmine: 4 indexed trials, 4 sponsors; 0 linked Orange Book patents and 8 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
8FDA-linked events
Development evidence
NCT00102284University Hospital Muenster · other_neurologyPHASE4
NCT01348282Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · dementia_otherPHASE4
NCT01856738Amsterdam UMC, location VUmc · parkinsonsPHASE4
NCT02444637National Neuroscience Institute · alzheimersPHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALRIVASTIGMINE · 2019-11-26
FDA_APPROVALRIVASTIGMINE · 2018-06-20
FDA_APPROVALRIVASTIGMINE TARTRATE · 2016-03-25
FDA_APPROVALRIVASTIGMINE TARTRATE · 2007-10-31
FDA_APPROVALRIVASTIGMINE TARTRATE · 2007-10-22
FDA_APPROVALEXELON · 2007-07-06
FDA_APPROVALEXELON · 2000-04-21
FDA_APPROVALEXELON · 2000-04-21
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.